MARK2 and Alzheimer disease: Although PAR1-Tau axis has been shown to play a crucial role in AD processes, which Aβ toxicity and/or other triggers are likely to impinge on20, it seems that kinase inhibition alone or inhibition of one kinase is not sufficient to achieve better clinical outcome.